- Home
- CRWD vs LLY Comparison
CRWD vs LLY Comparison
Compare CRWD & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRWD | LLY |
|---|---|---|
| Founded | 2011 | 1876 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.3B | 979.6B |
| IPO Year | 2019 | 2007 |
Fundamental Metrics
Financial Performance| Metric | CRWD | LLY |
|---|---|---|
| Price | $701.68 | $1,211.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 48 | 19 |
| Target Price | $507.00 | ★ $1,218.84 |
| AVG Volume (30 Days) | ★ 3.2M | 2.4M |
| Earning Date | 06-02-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.81% |
| EPS Growth | N/A | ★ 95.99 |
| EPS | 0.11 | ★ 8.26 |
| Revenue | $4,812,005,000.00 | ★ $65,179,000,000.00 |
| Revenue This Year | $24.85 | $27.15 |
| Revenue Next Year | $21.40 | $16.04 |
| P/E Ratio | $6,165.82 | ★ $136.56 |
| Revenue Growth | 21.71 | ★ 44.70 |
| 52 Week Low | $342.72 | $623.78 |
| 52 Week High | $785.66 | $1,182.73 |
Technical Indicators
Market Signals| Indicator | CRWD | LLY |
|---|---|---|
| Relative Strength Index (RSI) | 59.70 | 72.82 |
| Support Level | $463.35 | $1,032.70 |
| Resistance Level | $785.66 | N/A |
| Average True Range (ATR) | 31.68 | 37.16 |
| MACD | -7.46 | -0.76 |
| Stochastic Oscillator | 81.82 | 97.11 |
Price Performance
Historical ComparisonAbout CRWD CrowdStrike Holdings Inc.
CrowdStrike is a cloud-native cybersecurity company specializing in security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform, which provides enterprises with a unified view to detect and respond to security threats across their IT infrastructure. The Austin, Texas-based firm was founded in 2011 and went public in 2019.
About LLY Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.